期刊文献+

全身炎症反应综合征的靶器官保护 被引量:3

Target organ protected strategy on systemic inflammatory response syndrome
原文传递
导出
摘要 目的探讨全身炎症反应综合征(SIRS)的治疗方法。方法阳江市人民医院重症监护室2004年2月至2006年12月收治的SIRS患者108例随机分为两组,对照组(n=58例)按常规治疗,治疗组(n=50例)为保护炎症靶器官(肠道、肺脏、胰腺)加以下的治疗:①生大黄30g,水煎成200ml溶液,每13分2次口服或管饲。②盐酸氨溴索60mg,ivgtt,Bid。③乌司他丁40万U,iv,q8h。疗程5d。监测外周血白细胞(WBC)、高敏C反应蛋白(ks-CRP)、血清淀粉酶(AMY).氧合指数(PaO2/FiO2)的变化。统计学方法采用x^2检验、配对t检验和方差分析。结果两组治疗前各项监测指标差异无统计学意义(P〉0.05),治疗组hs-CRP、AMY均于治疗后第3天明显下降,WBC于治疗后第5天明显下降,PaO2/FiO2于治疗后第5天明显增加,各项指标的改善均优于对照组(P〈0.05或P〈0.01)。治疗组多器官功能障碍综合征(MODS)发生率降低(46.0%vs65.5%,P〈0.05),病死率降低但无统计学意义(42.0%vs56.9%,P〉0.05)。结论注重炎症靶器官保护可降低SIRS患者的MODS发生率。 Objective To explore the therapreutic approach to systemic inflammatory response syndrome (SIRS). Method One hundred and eight patients with SIRS form February 2004 through December 2006 in ICU of Yangjiang people' s hospital were randomly divided into treatment group ( n = 50) and control group ( n = 58). Both groups were given routine treatment, while those in the treatment group were given decocturn of Rhubarb 30 g, orally twice a day; Ambroxol HCL 60 rag, iv gtt, Bid and Ulinastatin (400 000 U, iv, Q8h, for 5 days for addition in order to protected organ included intestine, lungs and pancreas. White blood cell (WBC), high sensitive C-reactive protein (hs-CRP), amylase (AMY), PaO2/FiO2 were monitored during the course of pharmacological intervention. 7.2 test t, test and variance analysis were used for the statistical study. Results All the monitored indexes had no significant difference between two group before treatment. In the treatment group hs- CRP, AMY were significantly reduced at the 3rd day, WBC was significantly lowed at the 5th day; and PaO2/ FiO2 increased significantly at the 5th day after pharmacological intervention. All the monitor bio-markers were improved better than those in the control group ( P 〈 0.05 or P 〈 0.01 ). The incidence of MODS was significantly lower in the treatment group ( 46.0% vs 65.5%, P 〈 0.05), but the mortally between two groups was no difference at statistics (42.0% vs 56.9%, P 〉 0.05). Conclusions Intensive protected of target organ against SIRS by Rhubarb, Ambroxol Hcl and Ulinastain could reduced the incidence rate of MODS in patients with SIRS.
出处 《中华急诊医学杂志》 CAS CSCD 2008年第2期187-189,共3页 Chinese Journal of Emergency Medicine
关键词 全身炎症反应综合征 靶器官 治疗方法 生大黄 盐酸氨溴索 Systemic inflammatory response syndrome, SIRS Target organ Therapy Rheubarb Ambmxol Ulinastain
  • 相关文献

参考文献12

二级参考文献80

  • 1张晓隆,徐正祄,王万铁,王方岩,郝卯林,方周溪.肺缺血再灌注损伤时TXA_2/PGI_2平衡的变化及红花的调控作用[J].温州医学院学报,2004,34(5):328-330. 被引量:14
  • 2战晓芃,石耀辉,孙秀珍,陈国俊.急性心肌梗死发病与入院时C-反应蛋白水平的关系[J].中国急救医学,2001,21(1):20-21. 被引量:3
  • 3陈德昌,景炳文,张翔宇,王越波.大黄对肠粘膜屏障的保护作用[J].中国危重病急救医学,1994,6(6):329-331. 被引量:111
  • 4冯国辉,雷志礼,宇鹏,宁新宇,韦中余,李军,刘多辉,董兰,韩暑君,李会光.乌司他丁对原位肝移植术患者围术期肾功能的影响[J].中华麻醉学杂志,2005,25(11):853-855. 被引量:3
  • 5Santini V, Lamberts S W,Krenning E P,et al. Somatostatin and its cyclic octapeptide analog SMS 201-995 as inhibitors of proliferation of human acute lymphoblastic and acute myeloid leukemia. Leuk Res, 2000,24: 707.
  • 6Bone ND, Roger C. Risk distributions of 519 ICU admission for sepsis according to the definition of SIRS. Chest, 1992, 101:1481.
  • 7Tracey KJ, Lowry SF, Cerami A. Cachetin/FNF-alpha in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis, 1998, 138:1377.
  • 8SMALLING W E,SUGUIHAR C,HUANG J,et al.Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets[J].Biol Neonate,2004,86(1):15 -21.
  • 9ISHITSUKA Y,MORIUCH1 H,HATAMOTO K,et al.Involvement of thromboxane A2(TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel,a TXA2 synthase inhibitor,in guinea-pigs[J].J Pharm Pharmacol,2004,56(4):513-520.
  • 10ANVERSA P,LERI A,LI B,et al.Ischemic cardiomyopathy and the cellular renin-angiotensin system[J].J Heart Lung Transplant,2000,19(8 Suppl):S1-11.

共引文献256

同被引文献18

  • 1唐显映,张小明,董国礼,黄小华,杨汉丰,吴宇.肠梗阻的腹部X线平片和CT诊断[J].医学影像学杂志,2005,15(1):50-52. 被引量:44
  • 2潘利伟,孙来芳,郭蕾.乌司他丁治疗感染性休克的临床疗效观察[J].实用医学杂志,2005,21(11):1210-1211. 被引量:19
  • 3陈朴.乌司他丁治疗重症脓毒症患者的临床疗效分析[J].中国实用内科杂志,2005,25(9):802-804. 被引量:6
  • 4林洪远,管向东,周立新,艾宇航,王可富.乌司他丁、α1胸腺肽联合治疗严重脓毒症——一种新的免疫调理治疗方法的临床研究[J].中华医学杂志,2007,87(7):451-457. 被引量:100
  • 5陈灏珠.实用内科学[M].12版.北京:人民卫生出版社,2007:1789-1793.
  • 6LAPPAS J C,REYES B L,MAGLINTE D D.Abdominal radiography findings in small-bowel obstruction:relevance to triage for additional diagnostic imaging[J].AJR,2001,176(1):167-174.
  • 7Reinhart K, Brunkhorst FM, Bone HG, et al. Prevention, diagnosis, therapy and follow-up care of sepsis: 1 st revision of S-2k guidelines of the German Sepsis Society ( Deutsche Sepsis-Gesellschaft e. V. (DSG)) and the German interdisciplinary association of intensive care and emergency medicine ( Deutsche Interdisziplinore Vereinigung fur lntensivund Notfalhnedizin(DIV1) [ J ]. German Medical Science, 2010,8 : docl 4.
  • 8Vincent JL, Moreno R, Takala J, et al. The SOFA ( sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of European society of intensive care medicine[J].Intensive Care Med, 1996,22(7) :707-710.
  • 9Lappas JC,Reyes BL,Maglinte DD.Abdominal radiography findings in small-bowel obstruction:relevance to triage for additional diagnostic imaging[J].AJR,2001,176 (1):167-174.
  • 10石美.实用外科学[M].2版.北京:人民卫生出版社,2006:814.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部